Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using 90Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma
Titel:
Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using 90Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma
Auteur:
Mei, Matthew Palmer, Joycelynne Tsai, Nicole Ni-Chun Simpson, Jennifer O'Hearn, James Stein, Anthony Forman, Stephen Spielberger, Ricardo Cai, Ji-Lian Htut, Myo Nakamura, Ryotaro Al Malki, Monzr M. Herrera, Alex Wong, Jeffrey Nademanee, Auayporn